19 June 2024
19 June 2024
Sanofi is looking to strengthen its foothold in immunology by leveraging Belharra’s chemoproteomic platform for drug discovery.
Keeping high-qualified, experienced clinical trial staff on board plays a crucial role in bringing new drugs to market. Dana Durkan of KPS Life discusses how to avoid fraudulent staff, navigate work from home dynamics, and keep hold of your most valued employees.
The CDC Advisory Committee on Immunization Practices is expected to meet on 27 June to discuss the use of Capvaxive in adults.
Ascidian is entitled to receive up to $1.8bn in milestone payments on meeting research, clinical and commercial goals.
The approval expands the asset’s use in a range of inflammatory bowel disease indications.
The funding will be used to advance the Phase II development of MAR001 and other pipeline programmes.
Pyros’ Vigafyde will be available through a restricted programme due to a boxed warning in the second half (H2) of 2024.
Polaroid Therapeutics’ CEO suggests that pharma should partner with medtech to prevent antibiotic resistance in wound management.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
